Maternal serum screening for Down's syndrome on population basis

References

• Haddow J E, Palomaki G E, Knight G J, Williams J, Pulkkinen A, Canick J A, et al. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 1992; 327: 588–93
   PubMed Web of Science ®Google Scholar
• Wald N J, Kennard A, Densem J W, Cuckle H S, Chard T, Butler L. Antenatal maternal serum screening for Down's syndrome: results of a demonstration project. Br Med J 1992; 305: 391–4
   PubMed Web of Science ®Google Scholar
• Herrou M, Leporrier N, Leymarie P. Screening for fetal Down syndrome with maternal serum hCG and oestriol: a prospective study. Prenat Diagn 1992; 12: 887–92
   Google Scholar
• Phillips O P, Elias S, Shulman L P, Andersen R N, Morgan C D, Simpson J L. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha‐fetoprotein, hCG, and unconjugated oestriol: a prospective 2‐year study. Obstet Gynecol 1992; 80: 353–8
   PubMed Web of Science ®Google Scholar
• Cheng E Y, Luthy D A, Zebelman A M, Williams M A, Lieppman R E, Hickok D E. A prospective evaluation of a second‐trimester screening test for fetal Down syndrome using maternal serum aipha‐fetoprotein, hCG, and unconjugated oestriol. Obstet Gynecol 1993; 81: 72–7
   PubMed Web of Science ®Google Scholar
• Muller F, Aegerter P, Boue A. Prospective maternal serum human chorionic gonadotropin screening for the risk of fetal chromosome anomalies and of subsequent fetal and neonatal deaths. Prenat Diagn 1993; 13: 29–43
   PubMed Web of Science ®Google Scholar
• Burton B K, Prins G S, Verp M S. A prospective trial of prenatal screening for Down syndrome by means of maternal serum α‐fetoprotein, human chorionic gonadotropin, and unconjugated oestriol. Am J Obstet Gynecol 1993; 169: 526–30
   Google Scholar
• Spencer K, Carpenter P. Prospective study of prenatal screening for Down's syndrome with free 13 human chorionic gonadotrophin. Br Med J 1993; 307: 764–6
   Google Scholar
• Wenstrom K D, Williamson R A, Grant S S, Hudson J D, Getchell J R. Evaluation of multiple‐marker screening for Down syndrome in a statewide population. Am J Obstet Gynecol 1993; 169: 793–7
   Google Scholar
• Goodburn S F, Yates J RW, Raggatt P R, Carr C, Ferguson‐Smith M E, Kershaw A J, et al. Second‐trimester maternal serum screening using alpha‐fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme. Prenat Diagn 1994; 14: 391–402
   PubMed Web of Science ®Google Scholar
• Piggott M, Wilkinson P, Bennett J. Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne). J Med Screen 1994; 1: 45–9
   Google Scholar
• Salonen R, Simola K, Harjulehto‐Mervaala T, Aro T, Sax‐en L. Incidence of Down syndrome and prenatal diagnosis during the years 1984–1988 in Finland. Duodecim 1993; 109: 681–6
   PubMedGoogle Scholar
• Salonen R, Kurki L, Lappalainen M. Experiences of mothers participating in maternal serum screening for Down's syndrome. Eur J Hum Genet 1996; 4: 113–19
   PubMed Web of Science ®Google Scholar
• Wald N J, Cuckle H S, Densem J W, Nachanal K, Royston P, Chard T, et al. Maternal serum screening for Down's syndrome in early pregnancy. Br Med J 1988; 297: 883–7
   PubMed Web of Science ®Google Scholar
• Saller D N, Canick J A, Schwartz S, Blitzer M G. Multiple‐marker screening in pregnancies with hydropic and nonhydropic Turner syndrome. Am J Obstet Gynecol 1992; 167: 1021–4
   PubMedGoogle Scholar
• Wenstrom K D, Williamson R A, Grant S S. Detection of fetal Turner syndrome with multiple‐marker screening. Am J Obstet Gynecol 1994; 170: 570–3
   Google Scholar
• Knowles S, Flett R. Multiple marker screen positivity in the presence of hydrops fetalis. Prenat Diagn 1994; 14: 403–5
   PubMed Web of Science ®Google Scholar
• Rooney D E, Czepulkowski B H. Tissue culture methods in human cytogenetics. Human cytogenetics: a practical approach, D E Rooney, B H Czepulkowski. IRL Press Ltd, Oxford 1986; 1–37
   Google Scholar
• Wenstrom K D, Owen J, Boots L R, DuBard M B. Elevated second‐trimester human chorionic gonadotropin levels in association with poor pregnancy outcome. Am J Obstet Gynecol 1994; 171: 1038–41
   PubMed Web of Science ®Google Scholar
• Pergament E, Stein A K, Fiddler M, Cho N H, Kupferminc M J. Adverse pregnancy outcome after a false‐positive screen for Down syndrome using multiple markers. Obstet Gynecol 1995; 86: 255–8
   Google Scholar
• Kalousek D K, Langlois S, Barrett I, Yam I, Wilson D R, Howard Peebles P N, et al. Uniparental disomy for chromosome 16 in humans. Am J Hum Genet 1993; 52: 8–16
   PubMed Web of Science ®Google Scholar
• Wolstenholme J. An audit on trisomy 16 in man. Prenat Diagn 1995; 15: 109–21
   PubMed Web of Science ®Google Scholar